Recombinant human monoclonal IgA antibody against CEA to recruit neutrophils to CEA-expressing cells

Oncology Research

Volumn 17, Issue 5, 2008, Pages 217-222

  Zhao, Jun ^a   Kuroki, Motomu ^a   Shibaguchi, Hirotomo ^a   Wang, Lin ^a   Huo, Qun ^a   Takami, Noboru ^a   Tanaka, Toshihiro ^a   Kinugasa, Tetsushi ^a   Kuroki, Masahide ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Antibody dependent cellular cytotoxicity (ADCC); Carcinoembryonic antigen (CEA); IgA; Immunotherapy; Neutrophils

Indexed keywords

BACULOVIRUS VECTOR; CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; COMPLEMENTARY DNA; GENE PRODUCT; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G4 ANTIBODY; PROTEIN CHALPHA; RECOMBINANT ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGENICITY; ARTICLE; CANCER IMMUNOTHERAPY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG RESEARCH; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE AMPLIFICATION; GENE CONSTRUCT; GENE INSERTION; GENETIC TRANSFECTION; HEMOLYMPH; HUMAN; HUMAN CELL; HYBRIDOMA; INSECT CELL; LARVA; LEUKOCYTE ACTIVATION; MOLECULAR CLONING; MYELOMA CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SILKWORM; TUMOR CELL; VIRUS RECOMBINANT; VIRUS STRAIN; WESTERN BLOTTING;

EID: 57749183218     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504008786111374     Document Type: Article

References (26)

1. Kuroki, Ma.; Huang, J.; Shibaguch, H.; Tanaka, T.; Zhao, J.; Luo, N.; Hachimine, K.; Kinugasa, T.; Maekawa, T.; Enatsu, S.; Hamanaka, W.; Fukami, T.; Kuroki, Mo. Possible applications of antibodies or their genes in cancer therapy. Anticancer Res. 26:4019-4025; 2006.
2. Daeron, M. Fc receptor biology. Annu. Rev. Immunol. 15: 203-234; 1997.
3. Keler, T.; Wallace, P. K.; Vitale, L. A.; Russoniello, C.; Sundarapandiyan, K.; Graziano, R. F.; Deo, Y. M. Differential effect of cytokine treatment on Fc alpha receptor I-and Fc gamma receptor I-mediated tumor cytotoxicity by monocyte-derived macrophages. J. Immunol. 164:5746-5752; 2000.
4. Sulica, A.; Morel, P.; Metes, D.; Herberman, R. B. Ig-binding receptors on human NK cells as effector and regulatory surface molecules. Int. Rev. Immunol. 20:371-414; 2001.
5. Blumenthal, R. D.; Osorio, L.; Hayes, M. K.; Horak, I. D.; Hansen, H. J.; Goldenberg, D. M. Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograft. Cancer Immunol. Immunother. 54:315-327; 2005.
6. Huang, J.; Shibaguchi, H.; Zhao, J.; Luo, N.; Kuroki, Mo.; Kinugasa, T.; Hirose, Y.; Yamada, H.; Kuroki, Ma. IgG isotype conversion of a novel human anti-carcinoembryonic antigen antibody to increase its biological activity. Anticancer Res. 26:1057-1063; 2006.
7. Sundarapandiyan, K.; Keler, T.; Behnke, D.; Engert, A.; Barth, S.; Matthey, B.; Deo, Y. M.; Graziano, R. F. Bi-specific antibody-mediated destruction of Hodgkin's lymphoma cells. J. Immunol. Methods 248:113-123; 2001.
8. Stockmeyer, B.; Dechant, M.; van Egmond, M.; Tutt, A. L.; Sundarapandiyan, K.; Graziano, R. F.; Repp, R.; Kalden, J. R.; Gramatzki, M.; Glennie, M. J.; Van de Winkel, J. G.; Valerius, T. Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy. J. Immunol. 165:5954-5961; 2000.
9. Dechant, M.; Vidarsson, G.; Stockmeyer, B.; Repp, R.; Glennie, M. J.; Gramatzki, M.; Van de Winkel, J. G.; Valerius, T. Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing. Blood 100: 4574-4580; 2002.
10. Elsasser, D.; Stadick, H.; Stark, S.; Van de Winkel, J. G.; Gramatzki, M.; Schrott, K. M.; Valerius, T.; Schafhauser, W. Preclinical studies combining bispecific antibodies with cytokine-stimulated effector cells for immunotherapy of renal cell carcinoma. Anticancer Res. 19:1525-1528; 1999.
11. Huls, G.; Heijnen, I. A.; Cuomo, E.; Van der Linden, J.; Boel, E.; Van de Winkel, J. G.; Logtenberg, T. Antitumor immune effector mechanisms recruited by phage display-derived fully human IgG1 and IgA1 monoclonal antibodies. Cancer Res. 59:5778-5784; 1999.
12. Stockmeyer, B.; Elsasser, D.; Dechant, M.; Repp, R.; Gramatzki, M.; Glennie, M. J.; Van de Winkel, J. G.; Valerius, T. Mechanisms of G-CSF- or GM-CSF-stimulated tumor cell killing by Fc receptor-directed bispecific antibodies. J. Immunol. Methods 248:103-111; 2001.
13. Dechant, M.; Valerius, T. IgA antibodies for cancer therapy. Crit. Rev. Oncol. Hematol. 39:69-77; 2001.
14. Shibaguchi, H.; Kuroki, Mo.; Kuroki, Ma.; Badran, A.; Hachimine, K.; Kinugasa, T. Cloning and sequencing of variable region cDNAs of a novel human monoclonal antibody to carcinoembryonic antigen, and generation of a single chain variable fragmented antibody. Anticancer Res. 24:3355-3360; 2004.
15. Yamanaka, T.; Kuroki, M.; Kunugasa, T.; Matsuo, Y.; Matsuoka, Y. Preparation and characterization of two human carcinoembryonic antigen family proteins of neutrophils, CD66 b and c, in silkworm larvae. Protein Expres. Purif. 7:438-446; 1996.
16. Abe, H.; Kuroki, Mo.; Imakiire, Y.; Yamauchi, Y.; Yamada, H.; Arakawa, F.; Kuroki, Ma. Preparation of recombinant MK-1/Ep-CAM and establishment of an ELISA system for determining soluble MK-1/Ep-CAM levels in sera of cancer patients. J. Immunol. Methods 270:227-233; 2002.
17. Valerius, T.; Repp, R.; De Wit, T. P.; Berthold, S.; Platzer, E.; Kalden, J. R.; Gramatzki, M.; Van de Winkel, J. G. Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy. Blood 82:931-939; 1993.
18. Ishida, I.; Tomizuka, K.; Yoshida, H.; Tahara, T.; Takahashi, N.; Ohguma, A.; Tanaka, S.; Umehashi, M.; Maeda, H.; Nozaki, C.; Halk, E.; Lonberg, N. Production of human monoclonal and polyclonal antibodies in Trans-Chromo animals. Cloning Stem Cells 4:91-102; 2002.
19. Imakiire, T.; Kuroki, Mo.; Shibaguchi, H.; Abe, H.; Yamauchi, Y.; Ueno, A.; Hirose, Y.; Yamada, H.; Yamashita, Y.; Shirakusa, Y.; Ishida, I.; Kuroki, Ma. Generation, immunologic characterization and antitumor effects of human monoclonal antibodies for carcinoembryonic antigen. Int. J. Cancer 108:564-570; 2004.
20. Di Carlo, E.; Forni, G.; Lollini, P.; Colombo, M. P.; Modesti, A.; Musiani, P. The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 97:339-345; 2001.
21. Musiani, P.; Modesti, A.; Giovarelli, M.; Cavallo, F.; Colombo, M. P.; Lollini, P. L.; Forni, G. Cytokines, tumour-cell death and immunogenicity: a question of choice. Immunol. Today 18:32-36; 1997.
22. Honeychurch, J.; Tutt, A. L.; Valerius, T.; Heijnen, I. A.; Van de Winkel, J. G.; Glennie, M. J. Therapeutic efficacy of FcgammaRI/ CD64-directed bispecific antibodies in B-cell lymphoma. Blood 96:3544-3552; 2000.
23. Wurflein, D.; Dechant, M.; Stockmeyer, B.; Tutt, A. L.; Hu, P.; Repp, R.; Kalden, J. R.; Van de Winkel, J. G.; Epstein, A. L.; Valerius, T.; Glennie, M.; Gramatzki, M. Evaluating antibodies for their capacity to induce cell-mediated lysis of malignant B cells. Cancer Res. 58:3051-3058; 1998.
24. Valerius, T.; Stockmeyer, B.; Van Spriel, A. B.; Graziano, R. F.; Van den Herik-Oudijk, I. E.; Repp, R.; Deo, R. E.; Lund, J.; Kalden, J. R.; Gramatzki, M.; Van de Winkel, J. G. FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy. Blood 90:4485-4492; 1997.
25. Deo, Y. M.; Sundarapandiyan, K.; Keler, T.; Wallace, P. K.; Graziano, R. F. Bispecific molecules directed to the Fc receptor for IgA (Fc alpha RI, CD89) and tumor antigens efficiently promote cell-mediated cytotoxicity of tumor targets in whole blood. J. Immunol. 160:1677-1686; 1998.
26. Horner, H.; Frank, C.; Dechant, C.; Repp, R.; Glennie, M.; Herrmann, M.; Stockmeyer, B. Intimate cell conjugate formation and exchange of membrane lipids precede apoptosis induction in target cells during antibody-dependent, granulocyte-mediated cytotoxicity. J. Immunol. 179:337-345; 2007.